BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 17898005)

  • 1. Parkinson's disease, sleepiness and hypocretin/orexin.
    Baumann CR; Scammell TE; Bassetti CL
    Brain; 2008 Mar; 131(Pt 3):e91. PubMed ID: 17898005
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypocretin (orexin) loss and sleep disturbances in Parkinson's Disease.
    Fronczek R; Overeem S; Lee SY; Hegeman IM; van Pelt J; van Duinen SG; Lammers GJ; Swaab DF
    Brain; 2008 Jan; 131(Pt 1):e88. PubMed ID: 17898003
    [No Abstract]   [Full Text] [Related]  

  • 3. Progressive dopamine and hypocretin deficiencies in Parkinson's disease: is there an impact on sleep and wakefulness?
    Wienecke M; Werth E; Poryazova R; Baumann-Vogel H; Bassetti CL; Weller M; Waldvogel D; Storch A; Baumann CR
    J Sleep Res; 2012 Dec; 21(6):710-7. PubMed ID: 22747735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal hypocretin, daytime sleepiness and sleep architecture in Parkinson's disease dementia.
    Compta Y; Santamaria J; Ratti L; Tolosa E; Iranzo A; Muñoz E; Valldeoriola F; Casamitjana R; Ríos J; Marti MJ
    Brain; 2009 Dec; 132(Pt 12):3308-17. PubMed ID: 19858078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low levels of ventricular CSF orexin/hypocretin in advanced PD.
    Drouot X; Moutereau S; Nguyen JP; Lefaucheur JP; Créange A; Remy P; Goldenberg F; d'Ortho MP
    Neurology; 2003 Aug; 61(4):540-3. PubMed ID: 12939433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parkinson's disease comorbid with narcolepsy presenting low CSF hypocretin/orexin level.
    Maeda T; Nagata K; Kondo H; Kanbayashi T
    Sleep Med; 2006 Dec; 7(8):662. PubMed ID: 17097921
    [No Abstract]   [Full Text] [Related]  

  • 7. Hypocretin (orexin) loss in Parkinson's disease.
    Fronczek R; Overeem S; Lee SY; Hegeman IM; van Pelt J; van Duinen SG; Lammers GJ; Swaab DF
    Brain; 2007 Jun; 130(Pt 6):1577-85. PubMed ID: 17470494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excessive daytime sleepiness in Behçet's disease with diencephalic lesions and hypocretin dysfunction.
    Baumann CR; Bassetti CL; Hersberger M; Jung HH
    Eur Neurol; 2010; 63(3):190. PubMed ID: 20203518
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypocretin (orexin) and melanin concentrating hormone loss and the symptoms of Parkinson's disease.
    Thannickal TC; Lai YY; Siegel JM
    Brain; 2008 Jan; 131(Pt 1):e87. PubMed ID: 17898004
    [No Abstract]   [Full Text] [Related]  

  • 10. Low level of ventricular CSF orexin-A is not associated with objective sleepiness in PD.
    Drouot X; Moutereau S; Lefaucheur JP; Palfi S; Covali-Noroc A; Margarit L; Stoïca-Herman M; Nguyen JP; Césaro P; d'Ortho MP
    Sleep Med; 2011 Oct; 12(9):936-7. PubMed ID: 21978722
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypersomnia and low cerebrospinal fluid hypocretin levels in acute disseminated encephalomyelitis.
    Yoshikawa S; Suzuki S; Kanbayashi T; Nishino S; Tamai H
    Pediatr Neurol; 2004 Nov; 31(5):367-70. PubMed ID: 15519122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatigue in Parkinson's disease is not related to excessive sleepiness or quality of sleep.
    Havlikova E; van Dijk JP; Rosenberger J; Nagyova I; Middel B; Dubayova T; Gdovinova Z; Groothoff JW
    J Neurol Sci; 2008 Jul; 270(1-2):107-13. PubMed ID: 18371981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal hypocretin-1 levels in Parkinson's disease patients with excessive daytime sleepiness.
    Overeem S; van Hilten JJ; Ripley B; Mignot E; Nishino S; Lammers GJ
    Neurology; 2002 Feb; 58(3):498-9. PubMed ID: 11839864
    [No Abstract]   [Full Text] [Related]  

  • 14. Narcolepsy: selective hypocretin (orexin) neuronal loss and multiple signaling deficiencies.
    Bassetti CL
    Neurology; 2005 Oct; 65(8):1152-3. PubMed ID: 16247037
    [No Abstract]   [Full Text] [Related]  

  • 15. Sleep and Parkinson's disease.
    Freedom T
    Dis Mon; 2007 May; 53(5):275-90. PubMed ID: 17656189
    [No Abstract]   [Full Text] [Related]  

  • 16. Cerebrospinal fluid-orexin levels and sleep attacks in four patients with Parkinson's disease.
    Asai H; Hirano M; Furiya Y; Udaka F; Morikawa M; Kanbayashi T; Shimizu T; Ueno S
    Clin Neurol Neurosurg; 2009 May; 111(4):341-4. PubMed ID: 19097685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A patient with anti-aquaporin 4 antibody who presented with recurrent hypersomnia, reduced orexin (hypocretin) level, and symmetrical hypothalamic lesions.
    Nozaki H; Shimohata T; Kanbayashi T; Sagawa Y; Katada S; Satoh M; Onodera O; Tanaka K; Nishizawa M
    Sleep Med; 2009 Feb; 10(2):253-5. PubMed ID: 18226957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Narcolepsy-cataplexy associated with precocious puberty.
    Plazzi G; Parmeggiani A; Mignot E; Lin L; Scano MC; Posar A; Bernardi F; Lodi R; Tonon C; Barbiroli B; Montagna P; Cicognani A
    Neurology; 2006 May; 66(10):1577-9. PubMed ID: 16717224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normal levels of cerebrospinal fluid hypocretin-1 and daytime sleepiness during attacks of relapsing-remitting multiple sclerosis and monosymptomatic optic neuritis.
    Knudsen S; Jennum PJ; Korsholm K; Sheikh SP; Gammeltoft S; Frederiksen JL
    Mult Scler; 2008 Jul; 14(6):734-8. PubMed ID: 18505777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excessive daytime sleepiness and sleep episodes in Japanese patients with Parkinson's disease.
    Suzuki K; Miyamoto T; Miyamoto M; Okuma Y; Hattori N; Kamei S; Yoshii F; Utsumi H; Iwasaki Y; Iijima M; Hirata K
    J Neurol Sci; 2008 Aug; 271(1-2):47-52. PubMed ID: 18436241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.